1. Market Research
  2. > Healthcare Market Trends
  3. > Trends and Innovations in Patient Adherence

Trends and Innovations in Patient Adherence

  • March 2015
  • -
  • Firstword Pharma

Summary

Table of Contents




Taking the right dose of the right medicine at the right time is key to improving health outcomes, so why do so many patients fail to adhere to their treatment programme?

Trends and Innovations in Patient Adherenceis a thought-provoking and comprehensive report for everyone involved in ensuring patients comply with taking their medicines. The report provides extensive background information and is enriched by case studies. Most importantly, the report reveals the candid opinions of 16 leading experts from the pharma industry, health payers and patient advocacy groups in the US and Europe that present business-critical insights for pharma.

If one issue unites health payers, clinicians and the pharma industry, it is patient adherence. Clinicians want the best possible outcome for their patients, health payers need to ensure health spending is optimised and the industry wants clinical outcomes to reflect the safety and efficacy seen in trials. However a number of patients decide - for a variety of reasons – not to take their medicines as directed. The consequential cost of poor patient adherence is considerable, and changing behaviours is proving a challenge.

How can pharma improve its education and patient adherence programmes? What role can patient advocacy groups play? How do health payers assess value for money? What part could technological innovations play in modifying patient behaviour? Get answers to these questions in this new report.







Key Benefits

Understand the many and diverse drivers of patient non-compliance behaviour
Formulate strategies to improve adherence in specific patient groups
Assess the attitudes of health payers to non-adherence and identify collaborative opportunities to tackle it
Learn of multi-functional approaches to creating effective adherence programmes
Appreciate the importance of monitoring outcomes to support programmes and encourage use
Understand the technical innovations that will underpin drives to improve adherence and monitoring
Plan effective patient adherence programmes to ensure support is appropriate and sustained



Gain Answers to Critical Questions

What is the current understanding of the clinical, social, economic and personal factors that lead to poor patient adherence?
Is patient adherence all about the cost for health payers, and how do payers view current patient adherence programmes? How might patient non-adherence influence product strategies and research programmes?
What are the benefits of industry, patient groups and clinicians working together to develop optimal approaches for both acute and chronic conditions?
Digital innovations such as messaging reminders, electronic pill dispensers and smart pills can improve adherence and provide clinical feedback – where, how and when might they be used for best advantage?
What are the critical success factors for patient adherence programmes, and how will they evolve in the near future?


Key Takeaways

Learn the views and needs of health payers and patient groups when formulating patient education and support programmes
Review case studies on how industry is tackling the challenges
Identify the key behavioural drivers that lead to patient non adherence
Appreciate how digital innovation will influence this key area of industry
Key recommendations to maximise success of adherence programmes


Report Features

Knowledgeable and detailed “real world” opinions of 16 leading experts working daily in the patient adherence field across the US and Europe
Illustrative case studies demonstrating different approaches
A thought provoking assessment of the challenges for tackling patient non-compliance and how views in Europe and US differ
Critical insights for planning, marketing, brand management and stakeholder engagement



Expert Contributors

Pharma

European medical affairs manager at a global biopharmaceutical company
European marketing manager at a global pharmaceutical company
Global marketing manager at a major pharmaceutical company
Head of patient engagement, European pharmaceutical company


Payers

Pharmacy director at a national health insurer, US
Chief medical officer, managed care organisation (MCO), US
Vice president of a national pharmacy benefits manager (PBM), US
Medicines optimisation and prescribing lead at a large NHS clinical commissioning group (CCG), UK
Pharmacy director, France
Chief pharmacist, Italy
Chief pharmacist, Spain
Anonymous German KOL


Patient Opinion Leaders

Director, European Patients’ Academy on Therapeutic Innovation (EUPATI)
Board member of the European Parkinson’s Disease Association (EPDA)
Chief Executive of a myeloma support organisation
Founder and president of online community and resource centre for cancer patients, survivors and families




About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. FirstWord Reports provide expert views and intelligence on the challenges facing pharma today in these topic areas: Biosimilars, Market Access, Medical Affairs, Sales & Marketing, Technology, Therapy Areas.
FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.

Learn more at www.firstwordgroup.com.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.